Absci Investor Presentation Deck

Higher naturalness improves probability of success and expression levels ai. ABSCI CORPORATION 2023 ALL RIGHTS RESERVED REDUCED MA IMMUNOGENICITY 380 INCREASED DEVELOPABILITY HIGHER TITER Optimizing for naturalness with Absci's proprietary Al model to overcome major challenges in antibody development absci. 24

View entire presentation